Ogorek Anthony Joseph Merck & Co., Inc. Transaction History

Ogorek Anthony Joseph

$291 Million
Q3 2024

A detailed history of Ogorek Anthony Joseph transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ogorek Anthony Joseph holds 261 shares of MRK stock, worth $25,591. This represents 0.01% of its overall portfolio holdings.

Number of Shares

261

Previous 261 -0.0%

Holding current value

$25,591

Previous $32,000 9.38%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$100.18 - $109.02 $19,635 - $21,367	196 Added 301.54%	261 $28,000
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $1,194 - $1,302	-11 Reduced 14.47%	65 $7,000
Q4 2022 Jan 30, 2023	SELL	$87.44 - $112.11 $1,136 - $1,457	-13 Reduced 14.61%	76 $8,000
Q3 2022 Oct 20, 2022	SELL	$84.53 - $94.96 $26,119 - $29,342	-309 Reduced 77.64%	89 $7,000
Q2 2022 Jul 21, 2022	SELL	$83.49 - $94.64 $15,779 - $17,886	-189 Reduced 32.2%	398 $36,000
Q1 2022 Apr 26, 2022	SELL	$73.51 - $82.4 $336,234 - $376,897	-4,574 Reduced 88.63%	587 $48,000
Q4 2021 Jan 18, 2022	SELL	$72.28 - $90.54 $1.91 Million - $2.39 Million	-26,403 Reduced 83.65%	5,161 $395,000
Q3 2021 Oct 27, 2021	BUY	$71.68 - $78.83 $1,505 - $1,655	21 Added 0.07%	31,564 $2.37 Million
Q2 2021 Jul 14, 2021	BUY	$70.31 - $77.77 $64,052 - $70,848	911 Added 2.97%	31,543 $2.45 Million
Q1 2021 Apr 26, 2021	BUY	$68.86 - $81.11 $651,071 - $766,895	9,455 Added 44.65%	30,632 $2.36 Million
Q4 2020 Jan 20, 2021	BUY	$71.77 - $79.65 $46,004 - $51,055	641 Added 3.12%	21,177 $1.73 Million
Q3 2020 Nov 02, 2020	BUY	$73.18 - $82.95 $1.5 Million - $1.7 Million	20,536 New	20,536 $1.7 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.

Account

Ogorek Anthony Joseph Merck & Co., Inc. Transaction History